Details for New Drug Application (NDA): 070205
✉ Email this page to a colleague
NDA 070205 describes HYDRAMINE, which is a drug marketed by Alpharma Us Pharms and is included in two NDAs. Additional details are available on the HYDRAMINE profile page.
The generic ingredient in HYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in HYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 070205
| Tradename: | HYDRAMINE |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070205
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Jan 28, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
